EUDA Health Holdings Limited

EUDA Real Estate Real Estate Services

EUDA Health Holdings Limited’s revenue for fiscal 2025 (year ended December 2025) was $6.8 million, up 70.0% from fiscal 2024.

13.95 0.87 −5.87%
Market cap
$44.4M
P/E
0.0×
Fwd P/E
11.1×
Dividend yield
—
F-score
5/9
Altman Z
n/a
Beneish M
n/a
Dividend safety
n/a

Insider Decisions last twelve months

Trades a month
Jan 26 Apr 26 Jul 26 Oct 26
Buy — — — — — — — — — — — —
Sell — — — — — — — — — — — —
Insider Ownership 0.00%

Capital & Financial Ratios $m

Size
Market Cap 44.38
Revenue ttm —
Net income ttm (45.31)
Free cash flow ttm (4.52)
Net debt Q (7.89)
Valuation
P/E 0.00
Forward P/E 11.10
Price / sales 0.00
Forward P/S Powerpack
Price / FCF 0.00
Price / book 2.51
Financial health
Current ratio Q 2.53
Debt / equity Q 0.01
Interest coverage Q (173.40)
Growth
Revenue growth Q —
Operating income growth Q —
EPS, this year +900.00% (at or above 15%: strong)
EPS, next year A +209.09% (at or above 15%: strong)
Revenue, next year A +299.25% (at or above 10%: strong)
EPS, past 5 yrs —
EPS, next 5 yrs A —

Green and red mark values outside typical ranges; (Q) is the latest quarter, (A) analysts’ estimates. How we judge →

Valuation vs history

Dividends

Yield
—
Annual rate
—
Payout ratio
—

Assets vs Liabilities $m

2023 2024 2025 Q'26
Cash 0 0 0 8
Receivables 0 0 0 1
Inventory — 0 0 0
Other — — — —
1 1 1 9
2023 2024 2025 Q'26
Payables 0 1 1 0
ST’ Debt 1 1 2 0
Other — 0 1 0
9 4 6 4

Compound Annual Growth %

10y 5y 3y
Sales — (8.35%) 21.91%
Cash Flow — 0.00% 0.00%
Earnings — 0.00% 0.00%
Book Value — 0.00% 0.00%

EPS $

Jan Mar Apr Jul Year
’26 — — — — —
’25 — — — — (1.48)
’24 — — — — (9.40)
’23 — (2.40) — — (8.80)
’22 — — — — (41.48)
’22 (0.02) 0.49 (0.04) (0.09) (2.07)
’21 — — — — 1.95
Fiscal quarters ending in the months shown.

Revenue $m

Mar Jun Sep Dec Year
’26 — — — — —
’25 — — — — 7
’24 — — — — 4
’23 2 — — — 4
’22 — — — — 4
’22 3 — — — 10
’21 — — — — 11
Fiscal quarters ending in the months shown.

Operating Cash Flow $m

Jan Mar Apr Jul Year
’26 — — — — —
’25 — — — — (2)
’24 — — — — (2)
’23 — 0 — — (3)
’22 — — — — (2)
’22 0 0 (1) 0 (2)
’21 — — — — 0
Fiscal quarters ending in the months shown.

Free Cash Flow $m

Jan Mar Apr Jul Year
’26 — — — — —
’25 — — — — (3)
’24 — — — — (2)
’23 — 0 — — (3)
’22 — — — — (2)
’22 0 0 (1) 0 (2)
’21 — — — — 0
Fiscal quarters ending in the months shown.

Target Price Range

Analyst price targets

Recommendation Rating

1
1Buy 2 3Hold 4 5Sell

Ten years at a glance Fiscal years to December

Ten-year view Analyst estimates Powerpack
Group Line 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 TTM Jun ’26 Trend 10 yrs 2026e 2027e 2028e Next 3/yr
Income, $m
Income, $m Revenue — — — — — 11 4 4 4 7 — (10.3%) 27 — — +299.2%
Gross margin, % — — — — — 40.25 23.11 22.72 19.00 43.88 — +3.6 pt
EBT — — — — — 1 (25) (8) (18) (3) (9) n/m
EBT margin, % — — — — — 9.00 (664.90) (227.57) (439.85) (39.97) 0.00 (49.0) pt
Net income — 0 — — — 1 (25) (8) (18) (3) (45) n/m
Per share, $
Per share, $ Revenue — — — — — 22.79 6.26 3.24 2.47 3.65 0.00 (36.7%)
Earnings — — — — — 1.95 (37.27) (8.80) (9.40) (1.48) (2.75) n/m
Cash flow — — — — — 0.96 (2.54) (2.55) (1.25) (1.30) 0.00 n/m
Capex — — — — — 0.00 (0.03) 0.00 (0.07) (0.06) 0.00 +89.9%
Free cash flow — — — — — 0.96 (2.57) (2.55) (1.33) (1.35) 0.00 n/m
Book value — — — — — 1.30 (5.83) (6.53) (1.58) (2.28) 0.00 n/m
Shares, m — — — — — 0 1 1 2 2 11 +41.7%
Valuation, ×
Valuation, × P/E — — — — — 0.00 86.63 0.00 0.00 0.00 0.00 17.3
P/S — — — — — 0.00 0.00 0.00 0.00 0.00 0.00 0.0
P/B — — — — — 609.17 0.00 0.00 0.00 0.00 2.51 121.8
EV/Sales — — — — — 0.00 0.00 0.00 0.00 0.00 0.00 0.0
EV/FCF — — — — — 0.00 (142.60) (12.59) (26.72) (10.74) (1.57) (38.5)
Cash, $m
Cash, $m Operating cash flow — — — — — 0 (2) (3) (2) (2) (4) n/m
Capex — — — — — 0 0 — 0 0 0 +168.9%
Free cash flow — — — — — 0 (2) (3) (2) (3) (5) n/m
Balance, $m
Balance, $m Working capital — — — — — (3) (4) (8) (3) (5) 5 +12.8%
Net debt — — — — — 0 0 1 1 2 (8) +78.1%
Shareholders’ equity — — — — — 1 (4) (7) (3) (4) 6 n/m
Returns, %
Returns, % ROA — — — — — 10.81 (97.09) (74.53) (1,020.99) (162.42) 0.00 (173.2) pt
ROIC — — — — — (98.27) 0.00 0.00 0.00 0.00 0.00 +98.3 pt
ROE — — — — — 154.25 708.19 182.72 305.49 81.08 0.00 (73.2) pt
People
People Employees — — — — — — 150 106 117 123 — (6.4%)
Revenue/emp, $m — — — — — 0.00 0.03 0.03 0.03 0.06 — n/m
Negative figures in brackets.
estimates

All 10 years →

Fiscal years to Dec 2025 · latest quarter Mar 2023 · fundamentals updated 26 Oct 2026

EUDA Health Holdings Limited vs peers in Real Estate Services (Q) = latest quarter vs a year earlier

Company Market cap P/E Fwd P/E Revenue growth (Q) EPS growth (Q) FCF growth (Q) Gross margin (Q) EBIT margin (Q) Compare
SRG Seritage Growth Properties $94.6M — (loss-making) 10.8× −59.72% (below 0%: shrinking) n/m +10.60% (above 0%: growing) 38.90% (253.84%) Compare
STHO Star Holdings $91.5M 6.3× — −53.96% (below 0%: shrinking) n/m −263.07% (below 0%: shrinking) 27.41% 9.47% Compare
MAYS J. W. Mays, Inc. $88.7M — (loss-making) — (loss-making) −5.98% (below 0%: shrinking) n/m −125.91% (below 0%: shrinking) 26.59% (6.67%) Compare
ASPS Altisource Portfolio Solutions S.A. $65.4M — (loss-making) — (loss-making) +23.89% (above 0%: growing) n/m +317.79% (above 0%: growing) 23.35% 1.47% Compare
RFL Rafael Holdings, Inc. $55.3M — (loss-making) — (loss-making) −30.29% (below 0%: shrinking) n/m +19.32% (above 0%: growing) 94.67% (3,993.03%) Compare
EUDA EUDA Health Holdings Limited $44.4M — (loss-making) 11.1× — n/m −881.74% (below 0%: shrinking) 26.92% 0.00%
OMH Ohmyhome Limited $28.2M — — — — +88.25% (above 0%: growing) — — Compare
MDRR Medalist Diversified REIT, Inc. $21.3M 1.7× — (loss-making) −26.64% (below 0%: shrinking) n/m +144.90% (above 0%: growing) 64.43% (21.79%) Compare
DUO Fangdd Network Group $21.0M — (loss-making) — (loss-making) −15.35% (below 0%: shrinking) n/m +49.62% (above 0%: growing) 12.91% 0.00% Compare
Median of peers $60.4M — — −26.64% — +34.47% 27.41% (6.67%)

All 44 Real Estate Services stocks →

EUDA Health Holdings Limited (EUDA) Latest News

19 Mar

Impact 3 · · GlobeNewswire

10 Mar

13 Jan

Impact 4 · · GlobeNewswireSouth China Morning PostMT NewswiresMarketBeatClinical Trials ArenaMT NewswiresPharmaceutical TechnologySouth China Morning Post

7 Jan

Impact 3 · · GlobeNewswireHospital ManagementMT Newswires

22 Dec

Impact 3 · · MT Newswires

10 Sep

Impact 4 · · GlobeNewswire
stockrow.com/EUDA · Data as of Oct 26, 2026 · For information only; not investment advice. · © 2026 stockrow.com